Hannah Levy: Rethinking CAR-T and the Future of B-Cell Lymphoma Care
Hannah Levy/LinkedIn

Hannah Levy: Rethinking CAR-T and the Future of B-Cell Lymphoma Care

Hannah Levy, Scientific Intelligence Analyst and Global Moderator at MedNews Week, shared MedNews Week’s post on LinkedIn, adding:

“Not every day you get to see yourself turned into a comic!

Such a fun way to revisit this conversation with Dr. M. Bilal Abid and Adeena Musheer on CAR-T, access, survivorship, mentorship, and where cellular therapy is heading.

Very cool work by Diksha Sanjana Pasnoor and the MedNews Week team.”

Quoting MedNews Week’s post:

“MedNews Week Comics / Medical Spotlight, illustrated.

A different way to revisit an important conversation.

From the rapidly evolving landscape of CAR-T in aggressive B-cell lymphoma to access, survivorship, the next frontier of cellular therapy and the value of mentorship, here is our comic round-up of our Medical Spotlight with Dr M. Bilal Abid hosted by Adeena Musheer and Hannah Levy.

Grateful to Dr. Abid for sharing his expertise, experiences, and perspective with us.

Illustrated by our MedNews Week member, Diksha Sanjana Pasnoor.

Catch the full conversation here.”

Hannah Levy: Rethinking CAR-T and the Future of B-Cell Lymphoma Care

You can also read: The Current Landscape and Future of CAR-T in Aggressive B-Cell Lymphoma

Hannah Levy: Rethinking CAR-T and the Future of B-Cell Lymphoma Care